Completed OBSERVATIONAL NCT00613314

Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen

Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen (CENTER)

Sponsor: Boehringer Ingelheim

Conditions Hypertension Metabolic Syndrome X

Updated 8 times since 2017 Last updated: Apr 30, 2014 Started: Jun 30, 2007 Primary completion: Apr 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hypertension and Metabolic Syndrome X and is currently completed. Boehringer Ingelheim leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

8 versions recorded

Feb 2026 — Present [monthly]

Completed
Sep 2025 — Feb 2026 [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boehringer Ingelheim

Data source: Boehringer Ingelheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alaminos City, Pangasinan, Philippines , Angeles City, Philippines , Angeles City, Pampanga, Philippines , Antipolo City, Rizal, Philippines , Atabay, San Jose, Philippines , Bacoor, Cavite, Philippines , Baguio City, Benguet, Philippines , Balanga City, Bataan, Philippines , Baliuag, Balacan, Philippines , Baliuag, Bulacan, Philippines and 112 more locations